How I treat refractory chronic graft-versus-host disease
Author:
Affiliation:
1. Division of Hematological Malignancies and Cellular Therapy, Department of Medicine,
2. Duke Cancer Institute, and
3. Department of Dermatology, Duke University Medical Center, Durham, NC
Abstract
Publisher
American Society of Hematology
Subject
Cell Biology,Hematology,Immunology,Biochemistry
Link
http://ashpublications.org/blood/article-pdf/133/11/1191/1552649/blood785899.pdf
Reference113 articles.
1. Chronic graft versus host disease: a syndrome of disordered immunity;Graze;Am J Med,1979
2. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients;Shulman;Am J Med,1980
3. Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression;Sullivan;Blood,1981
4. Prospective, randomized, double-blind, phase III clinical trial of anti-T-lymphocyte globulin to assess impact on chronic graft-versus-host disease-free survival in patients undergoing HLA-matched unrelated myeloablative hematopoietic cell transplantation;Soiffer;J Clin Oncol,2017
5. Antilymphocyte globulin for prevention of chronic graft-versus-host disease;Kröger;N Engl J Med,2016
Cited by 65 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. How does ocular graft‐versus‐host disease fit under the dry eye umbrella? A review;Clinical & Experimental Ophthalmology;2024-01-10
2. Graft-Versus-Host Disease;Manual of Hematopoietic Cell Transplantation and Cellular Therapies;2024
3. A personalized, organ-based approach to the treatment of chronic steroid-refractory graft-versus-host disease;Blood Reviews;2024-01
4. More evidence for low-dose IL-2 for chronic GVHD in children;Blood Advances;2023-08-22
5. Ruxolitinib as the first post-steroid treatment for acute and chronic graft-versus-host disease;Expert Review of Clinical Immunology;2023-08-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3